Company Overview

Company name: Joint Venture (The Cannabis Oil Company / IPS Specials)
Description: Provider of CBD pharmaceuticals in United Kingdom. The company pairs pharmaceutical expertise of IPS with TCOC’s commercial capability, providing pharma-standard CBD to vitamins, minerals and supplements (VMS) markets, and specific pharmaceutical applications in the UK & Europe.
Year founded: 2019
Parent company:
Industry: Healthcare | Group: | Code:
Country: United Kingdom
Region: Europe

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was formed as a joint venture between IPS Specials and The Cannabis Oil Company on April 26, 2019. The venture is formed to grow share of the UK CBD market, initially making product available through 5,500 pharmacies, and then every pharmacy in the country.
Number of active investors:
Profile last updated: 30-Apr-2019
Last known valuation:
Last known valuation date: